Follow
nathan keller
nathan keller
Ariel university Israel
Verified email at sheba.health.gov.il
Title
Cited by
Cited by
Year
Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients
R Colodner, W Rock, B Chazan, N Keller, N Guy, W Sakran, R Raz
European journal of clinical microbiology and infectious diseases 23, 163-167, 2004
5762004
Bacterial induction of autoantibodies to β2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome
M Blank, I Krause, M Fridkin, N Keller, J Kopolovic, I Goldberg, A Tobar, ...
The Journal of clinical investigation 109 (6), 797-804, 2002
4352002
Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections
D Ben-David, R Kordevani, N Keller, I Tal, A Marzel, O Gal-Mor, Y Maor, ...
Clinical Microbiology and Infection 18 (1), 54-60, 2012
4262012
Nasopharyngeal Carriage of Streptococcus pneumoniae by Adults and Children in Community and Family Settings
G Regev-Yochay, M Raz, R Dagan, N Porat, B Shainberg, E Pinco, ...
Clinical Infectious Diseases 38 (5), 632-639, 2004
3972004
Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997–1999
DE Low, N Keller, A Barth, RN Jones
Clinical Infectious Diseases 32 (Supplement_2), S133-S145, 2001
3782001
An Outbreak of Phialemonium Infective Endocarditis Linked to Intracavernous Penile Injections for the Treatment of Impotence
J Strahilevitz, G Rahav, HJ Schroers, RC Summerbell, Z Amitai, ...
Clinical infectious diseases 40 (6), 781-786, 2005
3762005
Listeria monocytogenes infection in Israel and review of cases worldwide
Y Siegman-Igra, R Levin, M Weinberger, Y Golan, D Schwartz, Z Samra, ...
Emerging infectious diseases 8 (3), 305, 2002
2862002
Rhino-orbital and rhino-orbito-cerebral mucormycosis
YP Talmi, A Goldschmied-Reouven, M Bakon, I Barshack, M Wolf, ...
Otolaryngology—Head and Neck Surgery 127 (1), 22-31, 2002
2652002
Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection
D Ben-David, Y Maor, N Keller, G Regev-Yochay, I Tal, D Shachar, ...
Infection Control & Hospital Epidemiology 31 (6), 620-626, 2010
2172010
Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection
R Ben-Ami, K Olshtain-Pops, M Krieger, I Oren, J Bishara, M Dan, ...
Antimicrobial agents and chemotherapy 56 (5), 2518-2523, 2012
1942012
Clinical Features of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Bacteremia versus Those of Methicillin-Resistant S. aureus Bacteremia
Y Maor, M Hagin, N Belausov, N Keller, D Ben-David, G Rahav
The Journal of infectious diseases 199 (5), 619-624, 2009
1942009
Rapid Detection of blaKPC Carbapenemase Genes by Real-Time PCR
M Hindiyeh, G Smollen, Z Grossman, D Ram, Y Davidson, F Mileguir, ...
Journal of clinical microbiology 46 (9), 2879-2883, 2008
1942008
Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers
R Neeman, N Keller, A Barzilai, Z Korenman, S Sela
The Lancet 352 (9145), 1974-1977, 1998
1851998
Feasibility of using recombinant factor VIIa in continuous infusion
S Schulman, MB Jensen, D Varon, N Keller, N Gitel, H Horoszowski, ...
Thrombosis and haemostasis 75 (03), 432-436, 1996
1521996
The use of porphyrins for eradication of Staphylococcus aureus in burn wound infections
A Orenstein, D Klein, J Kopolovic, E Winkler, Z Malik, N Keller, Y Nitzan
FEMS Immunology & Medical Microbiology 19 (4), 307-314, 1997
1481997
Methicillin-resistant Staphylococcus aureus in neonatal intensive care unit
G Regev-Yochay, E Rubinstein, A Barzilai, Y Carmeli, J Kuint, J Etienne, ...
Emerging infectious diseases 11 (3), 453, 2005
1432005
Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality
M Weinberger, L Leibovici, S Perez, Z Samra, I Ostfeld, I Levi, E Bash, ...
Journal of Hospital Infection 61 (2), 146-154, 2005
1272005
Prevalence and Characteristics of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Bacteremia in a Tertiary Care Center
Y Maor, G Rahav, N Belausov, D Ben-David, G Smollan, N Keller
Journal of clinical microbiology 45 (5), 1511-1514, 2007
1162007
Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa
U Hedner
Thrombosis and haemostasis 82 (08), 531-539, 1999
1131999
Nosocomial bloodstream infections in a pediatric intensive care unit: 3-year survey
G Grisaru-Soen, Y Sweed, L Lerner-Geva, G Hirsh-Yechezkel, V Boyko, ...
Medical science monitor 13 (6), CR251-CR257, 2007
1102007
The system can't perform the operation now. Try again later.
Articles 1–20